These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 6113759)
1. Improved right ventricular function and reduced pulmonary vascular resistance during prazosin therapy of congestive heart failure. Colucci WS; Holman BL; Wynne J; Carabello B; Malacoff R; Grossman W; Braunwald E Am J Med; 1981 Jul; 71(1):75-80. PubMed ID: 6113759 [TBL] [Abstract][Full Text] [Related]
2. [Variable acute effects of prazosin on left ventricular failure (author's transl)]. Hepp A; Schick KD; Larbig D; Haasis R; Liebau G; Riegger G; Kochsiek K Dtsch Med Wochenschr; 1980 Nov; 105(47):1647-50. PubMed ID: 7439046 [TBL] [Abstract][Full Text] [Related]
3. The contributions of sympathetic tone and the renin-angiotensin system to severe chronic congestive heart failure: response to specific inhibitors (prazosin and captopril). Kluger J; Cody RJ; Laragh JH Am J Cardiol; 1982 May; 49(7):1667-74. PubMed ID: 7044087 [TBL] [Abstract][Full Text] [Related]
4. Importance of neuroendocrine regulators of vascular tone and integral adrenoreceptor interaction during oral vasodilator therapy of severe congestive heart failure with prazosin. Awan NA; Beattie JM; Evenson ME; Needham KE; Mason DT J Cardiovasc Pharmacol; 1982; 4 Suppl 1():S176-80. PubMed ID: 6175836 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic application of prazosin in chronic refractory congestive heart failure. Tolerance and "tachyphylaxis" in perspective. Awan NA; Needham KE; Evenson MK; Amsterdam EE; Mason DT Am J Med; 1981 Jul; 71(1):153-60. PubMed ID: 7246573 [TBL] [Abstract][Full Text] [Related]
6. Sustained effectiveness of chronic prazosin therapy in severe chronic congestive heart failure. Bertel O; Burkart F; Bühler FR Am Heart J; 1981 May; 101(5):529-33. PubMed ID: 7223592 [TBL] [Abstract][Full Text] [Related]
7. [Long-term therapy with oral prazosin in chronic congestive heart failure: a clinical and echocardiographic evaluation (author's transl)]. Sparvieri F; Cesari GP; Soro A G Ital Cardiol; 1980; 10(6):730-40. PubMed ID: 6780400 [TBL] [Abstract][Full Text] [Related]
8. Dynamic responses to continuous use of prazosin and hydralazine in patients with refractory heart failure. Elkayam U; Mathur M; Frishman W; LeJemtel T; Strom J; Sonnenblick EH Clin Pharmacol Ther; 1981 Jul; 30(1):23-30. PubMed ID: 7237894 [TBL] [Abstract][Full Text] [Related]
9. Hemodynamic responses to different levels of alpha-adrenergic interruption in congestive heart failure. Good AP; Unverferth DV; Leier CV Cardiovasc Drugs Ther; 1988 Jan; 1(5):529-34. PubMed ID: 2908715 [TBL] [Abstract][Full Text] [Related]
10. Effect of prostacyclin and prazosin in the treatment of congestive heart failure; with special reference to the sympathetic nervous system. Yui Y; Sakurai T; Nakajima H; Kawai C Jpn Circ J; 1984 Apr; 48(4):365-72. PubMed ID: 6371282 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of ibopamine plus prazosin in congestive heart failure. Naidoo DP; Rocke A; Mitha AS S Afr Med J; 1998 Feb; 88 Suppl 1():C25-31. PubMed ID: 9542492 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of ambulatory systemic vasodilator therapy with oral prazosin in chronic refractory heart failure. Concomitant relief of pulmonary congestion and elevation of pump output demonstrated by improvements in symptomatology, exercise tolerance, hemodynamics and echocardiography. Awan NA; Miller RR; DeMaria AN; Maxwell KS; Neumann A; Mason DT Circulation; 1977 Sep; 56(3):346-54. PubMed ID: 884789 [TBL] [Abstract][Full Text] [Related]
13. [Vasodilator therapy with alpha-receptor blockaders. Acute and chronic effect of prazosin and phentolamine in congestive heart failure]. Kersting F; Samosny G; Kasper W; Schuster HP Med Welt; 1981 Jun; 32(26):1040-5. PubMed ID: 6114383 [No Abstract] [Full Text] [Related]
14. Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure. Packer M; Medina N; Yushak M J Am Coll Cardiol; 1986 Mar; 7(3):671-80. PubMed ID: 2869077 [TBL] [Abstract][Full Text] [Related]
15. Development of pharmacodynamic tolerance to prozosin in congestive heart failure. Desch CE; Magorien RD; Triffon DW; Blanford MF; Unverferth DV; Leier CV Am J Cardiol; 1979 Nov; 44(6):1178-82. PubMed ID: 495512 [TBL] [Abstract][Full Text] [Related]
16. Alpha-adrenergic receptor blockade with prazosin. Consideration of hypertension, heart failure, and potential new applications. Colucci WS Ann Intern Med; 1982 Jul; 97(1):67-77. PubMed ID: 6124197 [TBL] [Abstract][Full Text] [Related]
17. [Effects of prazosin, SGB-1534, dobutamine and isoproterenol on congestive heart failure in dogs]. Sonoki H; Uchida Y; Tomaru T; Sugimoto T Nihon Yakurigaku Zasshi; 1988 Aug; 92(2):119-26. PubMed ID: 2906315 [TBL] [Abstract][Full Text] [Related]
18. Improved exercise ejection fraction with long-term prazosin therapy in patients with heart failure. Goldman SA; Johnson LL; Escala E; Cannon PJ; Weiss MB Am J Med; 1980 Jan; 68(1):36-42. PubMed ID: 7350803 [TBL] [Abstract][Full Text] [Related]